The capability of monitoring various cancer biomarkers in the DNA level, such as telomerase and carcinoembryonic antigen, opens a door for the use of nanowire-based DNA sensors for cancer diagnosis and treatment [33,73]. The gene discussed is CEACAM5; the disease is cancer.